Issue Date: October 6, 2008
Groups Back Vaccines For Malaria And Hiv
The Bill & Melinda Gates Foundation will provide $168.7 million to the PATH Malaria Vaccine Initiative, which is working on a malaria vaccine with GlaxoSmithKline Biologicals. The funding was unveiled at the United Nations Millennium Development Goals Malaria Summit, where almost $3 billion in malaria-fighting grants were announced. Meanwhile, Scripps Research Institute and the International AIDS Vaccine Initiative are spending $30 million on a new research center at Scripps dedicated to vaccines that elicit broadly neutralizing antibodies against HIV.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society